A phase II trial of neoadjuvant gemcitabine, cisplatin plus tislelizumab followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Clinical efficacy, safety and the biomarker analysis

被引：0
|
作者：
Li, Xiao-Yun
Xie, Si-Yi
Chen, Qiu-Yan
Mai, Hai-Qiang
Tang, Lin-Quan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4025
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Locoregionally advanced nasopharyngeal carcinoma:: Induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin -: A phase II study
    Ferrari, D.
    Chiesa, F.
    Codeca, C.
    Calabrese, L.
    Jereczek-Fossa, B. A.
    Alterio, D.
    Fiore, J.
    Luciani, A.
    Floriani, I.
    Orecchia, R.
    Foa, P.
    ONCOLOGY, 2008, 74 (3-4) : 158 - 166
  • [32] Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma
    Wu, Yuan
    Wei, Xueyan
    Yuan, Zilong
    Xu, Hongbin
    Li, Yanping
    Li, Ying
    Hu, Liu
    Han, Guang
    Qian, Yu
    Hu, Desheng
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (05) : 665 - 672
  • [33] Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A SecondaryAnalysis of a Prospective Phase III Clinical Trial
    Peng, Hao
    Chen, Lei
    Zhang, Yuan
    Li, Wen-Fei
    Mao, Yan-Ping
    Zhang, Fan
    Guo, Rui
    Liu, Li-Zhi
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    ONCOLOGIST, 2016, 21 (11): : 1369 - 1376
  • [34] Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma A Randomized Clinical Trial
    Miao, Jingjing
    Wang, Lin
    Tan, Sze Huey
    Li, Jin-Gao
    Yi, Junlin
    Ong, Enya H. W.
    Tan, Laura L. Y.
    Zhang, Ye
    Gong, Xiaochang
    Chen, Qiuyan
    Xiang, Yan-Qun
    Chen, Ming-Yuan
    Guo, Ying
    Lv, Xing
    Xia, Wei-Xiong
    Tang, Linquan
    Deng, Xiaowu
    Guo, Xiang
    Han, Fei
    Mai, Hai-Qiang
    Chua, Melvin L. K.
    Zhao, Chong
    JAMA ONCOLOGY, 2022, 8 (12) : 1776 - 1785
  • [35] A Phase II Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemotherapy with Cisplatin and Docetaxel for Locally Advanced Nasopharyngeal Carcinoma
    Zhang, Xinxin
    Du, Lei
    Zhao, Feifang
    Wang, Qiuju
    Yang, Shiming
    Ma, Lin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (04): : 446 - 453
  • [36] A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
    Liu, Tongxin
    Sun, Quanquan
    Chen, Jing
    Wang, Fangzheng
    Li, Bin
    Qin, Weifeng
    Ye, Zhimin
    Hu, Fujun
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6237 - 6245
  • [37] Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
    Chen, Yu-Pei
    Zhang, Wen-Na
    Tang, Ling-Long
    Mao, Yan-Ping
    Liu, Xu
    Chen, Lei
    Zhou, Guan-Qun
    Mai, Hai-Qiang
    Shao, Jian-Yong
    Jia, Wei-Hua
    Kang, Tie-Bang
    Zeng, Mu-Sheng
    Sun, Ying
    Ma, Jun
    BMC CANCER, 2015, 15
  • [38] Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
    Yu-Pei Chen
    Wen-Na Zhang
    Ling-Long Tang
    Yan-Ping Mao
    Xu Liu
    Lei Chen
    Guan-Qun Zhou
    Hai-Qiang Mai
    Jian-Yong Shao
    Wei-Hua Jia
    Tie-Bang Kang
    Mu-Sheng Zeng
    Ying Sun
    Jun Ma
    BMC Cancer, 15
  • [39] Weekly docetaxel concurrent chemoradiotherapy versus cisplatin in locoregionally advanced nasopharyngeal carcinoma: A propensity matched analysis
    Liao, J. F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Phase II neoadjuvant docetaxel/cisplatin followed by concurrent cisplatin/radiotherapy for locally advanced nasopharyngeal cancer
    Kandil, M. S.
    Alnasser, H. S.
    Bandey, S. A.
    Almutairy, A. S.
    Ammar, F. A.
    Saadeddin, A. A.
    Murshid, E. M.
    Asiri, M. A.
    Zahrani, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345